| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1103956827 |
| P356 | DOI | 10.1038/S41388-018-0273-5 |
| P932 | PMC publication ID | 6107480 |
| P698 | PubMed publication ID | 29755131 |
| P50 | author | Pedram Razavi | Q63869181 |
| James J Hsieh | Q88029561 | ||
| Sarat Chandarlapaty | Q88608703 | ||
| Qing Li | Q88654166 | ||
| P2093 | author name string | Omar Abdel-Wahab | |
| Nikolaus Schultz | |||
| Alessandro Pastore | |||
| Michael Berger | |||
| Amit Sinha | |||
| Young Rock Chung | |||
| Francisco Sanchez-Vega | |||
| Ronald Hendrickson | |||
| Kinisha Gala | |||
| Madeline Dorso | |||
| P2860 | cites work | Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo | Q73270417 |
| Model-based analysis of ChIP-Seq (MACS) | Q21183902 | ||
| Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins | Q24336785 | ||
| Multiplex genome engineering using CRISPR/Cas systems | Q24609428 | ||
| Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities | Q24617969 | ||
| Histone H3K27ac separates active from poised enhancers and predicts developmental state | Q24628758 | ||
| FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription | Q24645118 | ||
| Progesterone receptor modulates ERα action in breast cancer | Q27316268 | ||
| ESR1 ligand-binding domain mutations in hormone-resistant breast cancer | Q27852637 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer | Q28268284 | ||
| Whole-genome analysis informs breast cancer response to aromatase inhibition | Q28269291 | ||
| Mutational landscape and significance across 12 major cancer types | Q28300353 | ||
| A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs | Q28507017 | ||
| Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 | ||
| Genome-wide analysis of estrogen receptor binding sites | Q29614765 | ||
| STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
| DNA targeting specificity of RNA-guided Cas9 nucleases | Q29615793 | ||
| Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites | Q29620551 | ||
| Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells | Q30472602 | ||
| In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma | Q30936571 | ||
| Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer | Q33281087 | ||
| Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. | Q33352015 | ||
| HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4. | Q34238519 | ||
| Modification of enhancer chromatin: what, how, and why? | Q34331930 | ||
| featureCounts: an efficient general purpose program for assigning sequence reads to genomic features | Q34384848 | ||
| MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia | Q34386922 | ||
| H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation | Q34394362 | ||
| Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice | Q34444945 | ||
| FOXA1 is a key determinant of estrogen receptor function and endocrine response | Q34508204 | ||
| Histone methylases MLL1 and MLL3 coordinate with estrogen receptors in estrogen-mediated HOXB9 expression | Q34861446 | ||
| Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis | Q34979974 | ||
| A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4 | Q34980453 | ||
| Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing. | Q35032007 | ||
| An optimized microRNA backbone for effective single-copy RNAi | Q35065928 | ||
| HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment | Q35127065 | ||
| Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor | Q35193155 | ||
| Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice | Q35990241 | ||
| BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration | Q36021702 | ||
| BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis. | Q36506766 | ||
| Histone methyltransferase MLL3 contributes to genome-scale circadian transcription | Q36567973 | ||
| Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors | Q36710181 | ||
| Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance. | Q36902056 | ||
| Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol | Q36920160 | ||
| c-MYC partners with BPTF in human cancer. | Q37008590 | ||
| Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation | Q37176269 | ||
| Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation | Q37349731 | ||
| ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity | Q37369784 | ||
| Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance | Q38327743 | ||
| Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer | Q39093822 | ||
| Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor | Q39195669 | ||
| Integrative model of genomic factors for determining binding site selection by estrogen receptor-α | Q39616908 | ||
| Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. | Q41220529 | ||
| Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas | Q41251515 | ||
| Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells | Q41291278 | ||
| Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. | Q42972194 | ||
| Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase | Q45309214 | ||
| Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes. | Q48256635 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | DESeq2 | Q113018293 |
| GSVA | Q113334751 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4692-4710 | |
| P577 | publication date | 2018-05-14 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function | |
| P478 | volume | 37 |
| Q92564167 | Effect of the key histone modifications on the expression of genes related to breast cancer |
| Q92227242 | Genomic characterization of metastatic breast cancers |
| Q92853921 | Germline Variants in Driver Genes of Breast Cancer and Their Association with Familial and Early-Onset Breast Cancer Risk in a Chilean Population |
| Q92387567 | Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells |
| Q58718563 | Mechanisms for estrogen receptor expression in human cancer |
| Q90539392 | MutEx: a multifaceted gateway for exploring integrative pan-cancer genomic data |
| Q58699733 | TET2 coactivates gene expression through demethylation of enhancers |
| Q101476170 | Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort |
| Q94465327 | Whole-Genome Sequencing and Target Validation Analysis of Müllerian Adenosarcoma: A Tumor With Complex but Specific Genetic Alterations |
| Q99565341 | XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent way |
| Q61806992 | deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks |
Search more.